Zithromax Antibiotic Shouldn’t Be Used In Cancer Patients Getting Stem Cells, FDA Says

Mealey's (August 15, 2018, 11:48 AM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on Aug. 3 warned that the antibiotic Zithromax, also sold as Zmax and generically as azithromycin, should not be given long term to prevent an inflammatory lung condition in patients with blood or lymph node cancer who undergo a stem cell transplant to treat their disease because of the risk of recurring cancer and death....

Related Sections